Results 121 to 130 of about 686,182 (220)

ALK: Anaplastic lymphoma kinase

, 2013
Introduction Anaplastic lymphoma kinase, (also known as ALK, CD246 antigen, Ki 1 antigen, ALK tyrosine kinase receptor) is a member of the receptor tyrosine kinase (RTK) family. These proteins are essential for the transmission of extra-cellular signals to the interior of the cell and play essential roles in cellular activities including cell-cycle ...
openaire   +1 more source

Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: A rare entity

, 2014
Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: A rare ...
R Sachdev (13310379), N Sood (13310400), Sunil Gupta (13096512), S Goel (11926454)   +3 more
core  

Functional role of the CXCR4 chemokine receptor in thyroid cancer [PDF]

, 2009
Thyroid cancer is the most common endocrine malignancy and its incidence is increasing worldwide. We previously found that normal rat thyroid cells, transduced with papillary thyroid cancer (PTC)-related oncogenes, display an inflammatory signature, that
Avilla, Elvira
core  

A Rare Case of Anaplastic Lymphoma Kinase-negative Anaplastic Large Cell Lymphoma Presenting as Right Heart Failure

A 17-year-old male was admitted with progressive dyspnea on exertion, generalized edema, loss of appetite, and weight loss for 4 months. Clinical examination revealed features of right heart failure.
U. Harikishore, Rajesh Gopalan Nair, Madurai Shanmugasundaram Shivendrran, Sajeer Kalathingathodika   +3 more
core   +1 more source

Fetal Lung Interstitial Tumor: A Comprehensive Case Study with an Emphasis on Next-Generation Sequencing

Journal of Chest Surgery
Fetal lung interstitial tumor (FLIT), which is characterized by immature interstitial cells resembling the fetal lung parenchyma of 20 to 24 weeks of gestation, is a rare respiratory neoplasm. This study presents the first reported FLIT in Korea.
Yoo Jin Jung, Seongyeon Jung, Jiwon Koh, Jaemoon Koh, Yoon Kyung Jeon, Sung-Hye Park, Eun Na Kim, Chang Hyun Kang   +7 more
doaj   +1 more source

Three decades of anaplastic lymphoma kinase: from physiological roles to cancer and immune evasion. [PDF]

Cancer Metastasis Rev
Amin HM, Aminnia S, Saber MM, Kannan MK, Hung J.   +4 more
europepmc   +1 more source

First-Line Lorlatinib in Striatin-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma: A Case Report and Literature Review. [PDF]

Respirol Case Rep
Maebeya M, Tamura S, Shono T, Hoso T, Tatsuta H.   +4 more
europepmc   +1 more source

Genomic landscape and therapeutic implications of Anaplastic Lymphoma Kinase fusion-positive colorectal cancer. [PDF]

Oncologist
Li X, Yasin F, Pavlick DC, Ross JS, Cecchini M.   +4 more
europepmc   +1 more source

Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives. [PDF]

Front Immunol
Maccagno M, Tagliero R, Chiarle R, Voena C.   +3 more
europepmc   +1 more source

Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase-driven high-risk neuroblastoma. [PDF]

NPJ Precis Oncol
Xie W, Zhang Y, Lu S, Sun F, Zhu J, Que Y, Huang J, Song M, Zhen Z, Wang J, Zhang Y.   +10 more
europepmc   +1 more source